X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-26 | NGNE | Samsara Biocapital Gp, LLC | 10% | P - Purchase | $25.83 | +48,770 | 1,717,127 | +3% | +$1,259,623 | ||||||
2024-11-22 | NGNE | Cvijic Christine Mikail | Pres, CFO | P - Purchase | $20.48 | +24,000 | 76,844 | +45% | +$491,400 | ||||||
2024-11-22 | NGNE | McMinn Rachel | CEO | P - Purchase | $20.40 | +47,500 | 1,297,859 | +4% | +$969,000 | ||||||
| M | 2023-08-15 | NLTX | Baker Bros. Advisors LP | Dir, 10% | P - Purchase | $0.64 | +2,285,342 | 5,617,469 | +69% | +$1,463,487 | |||||
| D | 2023-08-11 | NLTX | Smith Sean Michael | Interim CFO, Prin Acct Off | S - Sale+OE | $0.62 | -1,323 | 21,637 | -6% | -$818 | |||||
| D | 2023-04-03 | NLTX | Patel Priti | Former Chief Medical Officer | S - Sale+OE | $0.69 | -3,769 | 37,313 | -9% | -$2,608 | |||||
| D | 2023-02-02 | NLTX | Smith Sean Michael | Principal Accounting Officer | S - Sale+OE | $0.60 | -3,316 | 15,960 | -17% | -$1,980 | |||||
| D | 2023-02-02 | NLTX | Patel Priti | Chief Medical Officer | S - Sale+OE | $0.60 | -14,380 | 31,082 | -32% | -$8,588 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |